JoVE
JoVE
Faculty Resource Center
Research
Behavior
Biochemistry
Biology
Bioengineering
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
JoVE Journal
JoVE Encyclopedia of Experiments
JoVE Chrome Extension
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to your Course
Authors
Librarians
High Schools
About
Sign-In
Sign In
Contact Us
Research
JoVE Journal
JoVE Encyclopedia of Experiments
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
High Schools
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Close
Research
Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
Products
JoVE Journal
JoVE Encyclopedia of Experiments
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
Products
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to Your Course
Teacher Resources
Get in Touch
Instant Trial
Log In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Journal
/
Cancer Research
/
Standardizing Ovarian Cancer Organoid Biobanking
/
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.
Sign in or start your free trial.
JoVE Journal
Cancer Research
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Standardizing Ovarian Cancer Organoid Biobanking
DOI:
10.3791/66467-v
•
02:12 min
•
February 23, 2024
•
Fabian Trillsch*
1,2
,
Juliane Reichenbach*
1
,
Bastian Czogalla
,
Fabian Kraus
,
Alexander Burges
,
Sven Mahner
2
,
Mirjana Kessler
2
1
Department of Obstetrics and Gynecology
,
University Hospital, Ludwig-Maximilian-University (LMU) Munich
,
2
German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich
Tags
Ovarian Cancer
Organoids
Biobanking
Patient-derived
Heterogeneity
Histological Subtypes
Disease Stages
Translational Research
Individualized Management
Predictive Biomarkers
Multivisceral Surgery
Chemotherapy
Anti-angiogenic Therapy
PARP Inhibitor
Homologous Recombination Deficiency
Biologic Models
Chemotherapy Response
Targeted Treatments
Culture Requirements
Renewal Potential
3D Culture
Standardization
Progenitor Cells
Experimental Workflow
2D/3D Seeding
Embed
ADD TO PLAYLIST
Usage Statistics
Related Videos
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Establishment of Ovarian Cancer Organoid Culture and its Evaluation
Ovarian Cancer Organoid Passaging and Cryopreservation for Long-Term Organoid Cultivation
Fixation of Ovarian Cancer Organoids for Long-Term Storage
Read Article